Back to Search Start Over

Effect of prenatal micronutrient-fortified balanced energy-protein supplementation on maternal and newborn body composition: A sub-study from the MISAME-III randomized controlled efficacy trial in rural Burkina Faso

Authors :
Sustainable Healthy Diets
Argaw, Alemayehu; Toe, Laeticia Celine; Hanley-Cook, Giles; Dailey-Chwalibóg, Trenton; de Kok, Brenda; Ouédraogo, Lionel; Compaoré, Anderson; Ouédraogo, Moctar; Sawadogo, Amadi; Ganaba, Rasmané; Vanslambrouck, Katrien; Kolsteren, Patrick; Lachat, Carl; Huybregts, Lieven
http://orcid.org/0000-0002-3068-2853 Huybregts, Lieven
Sustainable Healthy Diets
Argaw, Alemayehu; Toe, Laeticia Celine; Hanley-Cook, Giles; Dailey-Chwalibóg, Trenton; de Kok, Brenda; Ouédraogo, Lionel; Compaoré, Anderson; Ouédraogo, Moctar; Sawadogo, Amadi; Ganaba, Rasmané; Vanslambrouck, Katrien; Kolsteren, Patrick; Lachat, Carl; Huybregts, Lieven
http://orcid.org/0000-0002-3068-2853 Huybregts, Lieven
Source :
PLoS Med 20(7): e1004242
Publication Year :
2023

Abstract

PR<br />IFPRI3; ISI; DCA; Capacity Strengthening; 2 Promoting Healthy Diets and Nutrition for all<br />Nutrition, Diets, and Health (NDH); Food and Nutrition Policy<br />Background: Micronutrient-fortified balanced energy-protein (BEP) supplements are promising interventions to prevent intrauterine growth retardation in low- and middle-income countries. On the other hand, one concern with blanket prenatal supplementation programs using energy-dense supplements is that they could lead to more maternal and/or infant overweight. However, evidence is lacking on the potential effect of BEP on maternal and offspring body composition. This study evaluates the effects of micronutrient-fortified BEP supplementation during pregnancy on body composition of mothers and their newborns in rural Burkina Faso. Methods and findings: The MISAME-III study is an open label individually randomized controlled trial where pregnant women (n = 1,897) of gestational age <21 weeks received either a combination of micronutrient-fortified BEP and iron-folic acid (IFA) tablets (i.e., intervention) or IFA alone (i.e., control). The prenatal phase of the MISAME-III study was conducted between the first enrollment in October 2019 and the last delivery in August 2021. In a sub-study nested under the MISAME-III trial, we evaluated anthropometry and body composition in newborns who were born starting from 17 November 2020 (n: control = 368 and intervention = 352) and their mothers (n: control = 185 and intervention = 186). Primary study outcomes were newborn and maternal fat-free mass (FFMI) and fat-mass (FMI) indices. We used the deuterium dilution method to determine FFMI and FMI and %FFM and %FM of total body weight within 1 month postpartum. Our main analysis followed a modified intention-to-treat approach by analyzing all subjects with body composition data available. Univariable and multivariable linear regression models were fitted to compare the intervention and control arms, with adjusted models included baseline maternal age, height, arm fat index, hemoglobin concentration and primiparity, household size, wealth and food security indices, and newborn age (da

Details

Database :
OAIster
Journal :
PLoS Med 20(7): e1004242
Notes :
English, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1394144936
Document Type :
Electronic Resource